0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Needle-free Injection Systems Market Research Report 2026
Published Date: 2026-04-13
|
Report Code: QYRE-Auto-29T8919
Home | Market Reports | Health| Medical Devices & Equipment
Global Needle free Injection Systems Market Outlook 2022
BUY CHAPTERS

Global Needle-free Injection Systems Market Research Report 2026

Code: QYRE-Auto-29T8919
Report
2026-04-13
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Needle-free Injection Systems Market Size

The global Needle-free Injection Systems market was valued at US$ 231 million in 2025 and is anticipated to reach US$ 325 million by 2032, at a CAGR of 5.1% from 2026 to 2032.

Needle-free Injection Systems Market

Needle-free Injection Systems Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Needle-free Injection Systems competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
This report delivers a comprehensive overview of the global Needle-free Injection Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Needle-free Injection Systems. The Needle-free Injection Systems market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Needle-free Injection Systems market comprehensively. Regional market sizes by Power, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Needle-free Injection Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Power, by Application, and by region.
Market Segmentation

Scope of Needle-free Injection Systems Market Report

Report Metric Details
Report Name Needle-free Injection Systems Market
Accounted market size in 2025 US$ 231 million
Forecasted market size in 2032 US$ 325 million
CAGR 5.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Power
  • Reusable Injector
  • Single-use Injector
by Application
  • Vaccine Delivery
  • Insulin Delivery
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Antares Pharma, Endo International plc, Inovio Pharmaceuticals, Injex Pharma, National Medical Products Inc (J-Tip), Recipharm, European Pharma Group (InsuJet), Miracle Medical, Medical International Technology (MIT), Akra Dermojet, PharmaJet, Portal Instruments, Crossject Medical Technology, MIKA MEDICAL, Ferring Pharmaceuticals, D'Antonio Consultants International, Lepu Medical, TECHiJET
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Power, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Needle-free Injection Systems manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Needle-free Injection Systems sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Power, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Needle-free Injection Systems Market growing?

Ans: The Needle-free Injection Systems Market witnessing a CAGR of 5.1% during the forecast period 2026-2032.

What is the Needle-free Injection Systems Market size in 2032?

Ans: The Needle-free Injection Systems Market size in 2032 will be US$ 325 million.

What is the Antares Pharma, Endo International plc, Inovio Pharmaceuticals share in Needle-free Injection Systems Market?

Ans: Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market.

What is the Needle-free Injection Systems Market share by application?

Ans: The most common application is Insulin Delivery, with a share over 56%.

Who are the main players in the Needle-free Injection Systems Market report?

Ans: The main players in the Needle-free Injection Systems Market are Antares Pharma, Endo International plc, Inovio Pharmaceuticals, Injex Pharma, National Medical Products Inc (J-Tip), Recipharm, European Pharma Group (InsuJet), Miracle Medical, Medical International Technology (MIT), Akra Dermojet, PharmaJet, Portal Instruments, Crossject Medical Technology, MIKA MEDICAL, Ferring Pharmaceuticals, D'Antonio Consultants International, Lepu Medical, TECHiJET

What are the Application segmentation covered in the Needle-free Injection Systems Market report?

Ans: The Applications covered in the Needle-free Injection Systems Market report are Vaccine Delivery, Insulin Delivery, Others

1 Needle-free Injection Systems Market Overview
1.1 Product Definition
1.2 Needle-free Injection Systems by Power
1.2.1 Global Needle-free Injection Systems Market Value by Power: 2025 vs 2032
1.2.2 Reusable Injector
1.2.3 Single-use Injector
1.3 Needle-free Injection Systems by Application
1.3.1 Global Needle-free Injection Systems Market Value by Application: 2025 vs 2032
1.3.2 Vaccine Delivery
1.3.3 Insulin Delivery
1.3.4 Others
1.4 Global Needle-free Injection Systems Market Size Estimates and Forecasts
1.4.1 Global Needle-free Injection Systems Revenue 2021–2032
1.4.2 Global Needle-free Injection Systems Sales 2021–2032
1.4.3 Global Needle-free Injection Systems Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Needle-free Injection Systems Market Competition by Manufacturers
2.1 Global Needle-free Injection Systems Sales Market Share by Manufacturers (2021–2026)
2.2 Global Needle-free Injection Systems Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Needle-free Injection Systems Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Needle-free Injection Systems, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Needle-free Injection Systems, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Needle-free Injection Systems, Product Types and Applications
2.7 Global Key Manufacturers of Needle-free Injection Systems, Date of Entry into the Industry
2.8 Global Needle-free Injection Systems Market Competitive Situation and Trends
2.8.1 Global Needle-free Injection Systems Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Needle-free Injection Systems Players Market Share by Revenue
2.8.3 Global Needle-free Injection Systems Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Needle-free Injection Systems Market Scenario by Region
3.1 Global Needle-free Injection Systems Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Needle-free Injection Systems Sales by Region: 2021–2032
3.2.1 Global Needle-free Injection Systems Sales by Region: 2021–2026
3.2.2 Global Needle-free Injection Systems Sales by Region: 2027–2032
3.3 Global Needle-free Injection Systems Revenue by Region: 2021–2032
3.3.1 Global Needle-free Injection Systems Revenue by Region: 2021–2026
3.3.2 Global Needle-free Injection Systems Revenue by Region: 2027–2032
3.4 North America Needle-free Injection Systems Market Facts & Figures by Country
3.4.1 North America Needle-free Injection Systems Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Needle-free Injection Systems Sales by Country (2021–2032)
3.4.3 North America Needle-free Injection Systems Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Needle-free Injection Systems Market Facts & Figures by Country
3.5.1 Europe Needle-free Injection Systems Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Needle-free Injection Systems Sales by Country (2021–2032)
3.5.3 Europe Needle-free Injection Systems Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-free Injection Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Needle-free Injection Systems Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Needle-free Injection Systems Sales by Region (2021–2032)
3.6.3 Asia Pacific Needle-free Injection Systems Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Needle-free Injection Systems Market Facts & Figures by Country
3.7.1 Latin America Needle-free Injection Systems Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Needle-free Injection Systems Sales by Country (2021–2032)
3.7.3 Latin America Needle-free Injection Systems Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Needle-free Injection Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Needle-free Injection Systems Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Needle-free Injection Systems Sales by Country (2021–2032)
3.8.3 Middle East and Africa Needle-free Injection Systems Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Power
4.1 Global Needle-free Injection Systems Sales by Power (2021–2032)
4.1.1 Global Needle-free Injection Systems Sales by Power (2021–2026)
4.1.2 Global Needle-free Injection Systems Sales by Power (2027–2032)
4.1.3 Global Needle-free Injection Systems Sales Market Share by Power (2021–2032)
4.2 Global Needle-free Injection Systems Revenue by Power (2021–2032)
4.2.1 Global Needle-free Injection Systems Revenue by Power (2021–2026)
4.2.2 Global Needle-free Injection Systems Revenue by Power (2027–2032)
4.2.3 Global Needle-free Injection Systems Revenue Market Share by Power (2021–2032)
4.3 Global Needle-free Injection Systems Price by Power (2021–2032)
5 Segment by Application
5.1 Global Needle-free Injection Systems Sales by Application (2021–2032)
5.1.1 Global Needle-free Injection Systems Sales by Application (2021–2026)
5.1.2 Global Needle-free Injection Systems Sales by Application (2027–2032)
5.1.3 Global Needle-free Injection Systems Sales Market Share by Application (2021–2032)
5.2 Global Needle-free Injection Systems Revenue by Application (2021–2032)
5.2.1 Global Needle-free Injection Systems Revenue by Application (2021–2026)
5.2.2 Global Needle-free Injection Systems Revenue by Application (2027–2032)
5.2.3 Global Needle-free Injection Systems Revenue Market Share by Application (2021–2032)
5.3 Global Needle-free Injection Systems Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Antares Pharma
6.1.1 Antares Pharma Company Information
6.1.2 Antares Pharma Description and Business Overview
6.1.3 Antares Pharma Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Antares Pharma Needle-free Injection Systems Product Portfolio
6.1.5 Antares Pharma Recent Developments/Updates
6.2 Endo International plc
6.2.1 Endo International plc Company Information
6.2.2 Endo International plc Description and Business Overview
6.2.3 Endo International plc Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Endo International plc Needle-free Injection Systems Product Portfolio
6.2.5 Endo International plc Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Company Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Injex Pharma
6.4.1 Injex Pharma Company Information
6.4.2 Injex Pharma Description and Business Overview
6.4.3 Injex Pharma Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Injex Pharma Needle-free Injection Systems Product Portfolio
6.4.5 Injex Pharma Recent Developments/Updates
6.5 National Medical Products Inc (J-Tip)
6.5.1 National Medical Products Inc (J-Tip) Company Information
6.5.2 National Medical Products Inc (J-Tip) Description and Business Overview
6.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Portfolio
6.5.5 National Medical Products Inc (J-Tip) Recent Developments/Updates
6.6 Recipharm
6.6.1 Recipharm Company Information
6.6.2 Recipharm Description and Business Overview
6.6.3 Recipharm Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Recipharm Needle-free Injection Systems Product Portfolio
6.6.5 Recipharm Recent Developments/Updates
6.7 European Pharma Group (InsuJet)
6.7.1 European Pharma Group (InsuJet) Company Information
6.7.2 European Pharma Group (InsuJet) Description and Business Overview
6.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Product Portfolio
6.7.5 European Pharma Group (InsuJet) Recent Developments/Updates
6.8 Miracle Medical
6.8.1 Miracle Medical Company Information
6.8.2 Miracle Medical Description and Business Overview
6.8.3 Miracle Medical Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Miracle Medical Needle-free Injection Systems Product Portfolio
6.8.5 Miracle Medical Recent Developments/Updates
6.9 Medical International Technology (MIT)
6.9.1 Medical International Technology (MIT) Company Information
6.9.2 Medical International Technology (MIT) Description and Business Overview
6.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Medical International Technology (MIT) Needle-free Injection Systems Product Portfolio
6.9.5 Medical International Technology (MIT) Recent Developments/Updates
6.10 Akra Dermojet
6.10.1 Akra Dermojet Company Information
6.10.2 Akra Dermojet Description and Business Overview
6.10.3 Akra Dermojet Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Akra Dermojet Needle-free Injection Systems Product Portfolio
6.10.5 Akra Dermojet Recent Developments/Updates
6.11 PharmaJet
6.11.1 PharmaJet Company Information
6.11.2 PharmaJet Description and Business Overview
6.11.3 PharmaJet Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 PharmaJet Needle-free Injection Systems Product Portfolio
6.11.5 PharmaJet Recent Developments/Updates
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Description and Business Overview
6.12.3 Portal Instruments Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Portal Instruments Needle-free Injection Systems Product Portfolio
6.12.5 Portal Instruments Recent Developments/Updates
6.13 Crossject Medical Technology
6.13.1 Crossject Medical Technology Company Information
6.13.2 Crossject Medical Technology Description and Business Overview
6.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Crossject Medical Technology Needle-free Injection Systems Product Portfolio
6.13.5 Crossject Medical Technology Recent Developments/Updates
6.14 MIKA MEDICAL
6.14.1 MIKA MEDICAL Company Information
6.14.2 MIKA MEDICAL Description and Business Overview
6.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 MIKA MEDICAL Needle-free Injection Systems Product Portfolio
6.14.5 MIKA MEDICAL Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Description and Business Overview
6.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Ferring Pharmaceuticals Needle-free Injection Systems Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
6.16 D'Antonio Consultants International
6.16.1 D'Antonio Consultants International Company Information
6.16.2 D'Antonio Consultants International Description and Business Overview
6.16.3 D'Antonio Consultants International Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 D'Antonio Consultants International Needle-free Injection Systems Product Portfolio
6.16.5 D'Antonio Consultants International Recent Developments/Updates
6.17 Lepu Medical
6.17.1 Lepu Medical Company Information
6.17.2 Lepu Medical Description and Business Overview
6.17.3 Lepu Medical Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Lepu Medical Needle-free Injection Systems Product Portfolio
6.17.5 Lepu Medical Recent Developments/Updates
6.18 TECHiJET
6.18.1 TECHiJET Company Information
6.18.2 TECHiJET Description and Business Overview
6.18.3 TECHiJET Needle-free Injection Systems Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 TECHiJET Needle-free Injection Systems Product Portfolio
6.18.5 TECHiJET Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-free Injection Systems Industry Chain Analysis
7.2 Needle-free Injection Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-free Injection Systems Production Mode & Process Analysis
7.4 Needle-free Injection Systems Sales and Marketing
7.4.1 Needle-free Injection Systems Sales Channels
7.4.2 Needle-free Injection Systems Distributors
7.5 Needle-free Injection Systems Customer Analysis
8 Needle-free Injection Systems Market Dynamics
8.1 Needle-free Injection Systems Industry Trends
8.2 Needle-free Injection Systems Market Drivers
8.3 Needle-free Injection Systems Market Challenges
8.4 Needle-free Injection Systems Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Needle-free Injection Systems Market Value by Power (US$ Million), 2025 vs 2032
 Table 2. Global Needle-free Injection Systems Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Needle-free Injection Systems Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Needle-free Injection Systems Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Needle-free Injection Systems Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Needle-free Injection Systems Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Needle-free Injection Systems Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Needle-free Injection Systems Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Needle-free Injection Systems, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Needle-free Injection Systems, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Needle-free Injection Systems, Product Types and Applications
 Table 12. Global Key Manufacturers of Needle-free Injection Systems, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Needle-free Injection Systems Companies by Tier (Tier 1, Tier 2, Tier 3), based on Needle-free Injection Systems Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Needle-free Injection Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Needle-free Injection Systems Sales by Region (K Units), 2021–2026
 Table 18. Global Needle-free Injection Systems Sales Market Share by Region (2021–2026)
 Table 19. Global Needle-free Injection Systems Sales by Region (K Units), 2027–2032
 Table 20. Global Needle-free Injection Systems Sales Market Share by Region (2027–2032)
 Table 21. Global Needle-free Injection Systems Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Needle-free Injection Systems Revenue Market Share by Region (2021–2026)
 Table 23. Global Needle-free Injection Systems Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Needle-free Injection Systems Revenue Market Share by Region (2027–2032)
 Table 25. North America Needle-free Injection Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Needle-free Injection Systems Sales by Country (K Units), 2021–2026
 Table 27. North America Needle-free Injection Systems Sales by Country (K Units), 2027–2032
 Table 28. North America Needle-free Injection Systems Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Needle-free Injection Systems Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Needle-free Injection Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Needle-free Injection Systems Sales by Country (K Units), 2021–2026
 Table 32. Europe Needle-free Injection Systems Sales by Country (K Units), 2027–2032
 Table 33. Europe Needle-free Injection Systems Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Needle-free Injection Systems Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Needle-free Injection Systems Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Needle-free Injection Systems Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Needle-free Injection Systems Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Needle-free Injection Systems Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Needle-free Injection Systems Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Needle-free Injection Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Needle-free Injection Systems Sales by Country (K Units), 2021–2026
 Table 42. Latin America Needle-free Injection Systems Sales by Country (K Units), 2027–2032
 Table 43. Latin America Needle-free Injection Systems Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Needle-free Injection Systems Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Needle-free Injection Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Needle-free Injection Systems Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Needle-free Injection Systems Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Needle-free Injection Systems Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Needle-free Injection Systems Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Needle-free Injection Systems Sales (K Units) by Power (2021–2026)
 Table 51. Global Needle-free Injection Systems Sales (K Units) by Power (2027–2032)
 Table 52. Global Needle-free Injection Systems Sales Market Share by Power (2021–2026)
 Table 53. Global Needle-free Injection Systems Sales Market Share by Power (2027–2032)
 Table 54. Global Needle-free Injection Systems Revenue (US$ Million) by Power (2021–2026)
 Table 55. Global Needle-free Injection Systems Revenue (US$ Million) by Power (2027–2032)
 Table 56. Global Needle-free Injection Systems Revenue Market Share by Power (2021–2026)
 Table 57. Global Needle-free Injection Systems Revenue Market Share by Power (2027–2032)
 Table 58. Global Needle-free Injection Systems Price (US$/Unit) by Power (2021–2026)
 Table 59. Global Needle-free Injection Systems Price (US$/Unit) by Power (2027–2032)
 Table 60. Global Needle-free Injection Systems Sales (K Units) by Application (2021–2026)
 Table 61. Global Needle-free Injection Systems Sales (K Units) by Application (2027–2032)
 Table 62. Global Needle-free Injection Systems Sales Market Share by Application (2021–2026)
 Table 63. Global Needle-free Injection Systems Sales Market Share by Application (2027–2032)
 Table 64. Global Needle-free Injection Systems Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Needle-free Injection Systems Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Needle-free Injection Systems Revenue Market Share by Application (2021–2026)
 Table 67. Global Needle-free Injection Systems Revenue Market Share by Application (2027–2032)
 Table 68. Global Needle-free Injection Systems Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Needle-free Injection Systems Price (US$/Unit) by Application (2027–2032)
 Table 70. Antares Pharma Company Information
 Table 71. Antares Pharma Description and Business Overview
 Table 72. Antares Pharma Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Antares Pharma Needle-free Injection Systems Product
 Table 74. Antares Pharma Recent Developments/Updates
 Table 75. Endo International plc Company Information
 Table 76. Endo International plc Description and Business Overview
 Table 77. Endo International plc Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Endo International plc Needle-free Injection Systems Product
 Table 79. Endo International plc Recent Developments/Updates
 Table 80. Inovio Pharmaceuticals Company Information
 Table 81. Inovio Pharmaceuticals Description and Business Overview
 Table 82. Inovio Pharmaceuticals Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Inovio Pharmaceuticals Needle-free Injection Systems Product
 Table 84. Inovio Pharmaceuticals Recent Developments/Updates
 Table 85. Injex Pharma Company Information
 Table 86. Injex Pharma Description and Business Overview
 Table 87. Injex Pharma Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Injex Pharma Needle-free Injection Systems Product
 Table 89. Injex Pharma Recent Developments/Updates
 Table 90. National Medical Products Inc (J-Tip) Company Information
 Table 91. National Medical Products Inc (J-Tip) Description and Business Overview
 Table 92. National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. National Medical Products Inc (J-Tip) Needle-free Injection Systems Product
 Table 94. National Medical Products Inc (J-Tip) Recent Developments/Updates
 Table 95. Recipharm Company Information
 Table 96. Recipharm Description and Business Overview
 Table 97. Recipharm Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Recipharm Needle-free Injection Systems Product
 Table 99. Recipharm Recent Developments/Updates
 Table 100. European Pharma Group (InsuJet) Company Information
 Table 101. European Pharma Group (InsuJet) Description and Business Overview
 Table 102. European Pharma Group (InsuJet) Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. European Pharma Group (InsuJet) Needle-free Injection Systems Product
 Table 104. European Pharma Group (InsuJet) Recent Developments/Updates
 Table 105. Miracle Medical Company Information
 Table 106. Miracle Medical Description and Business Overview
 Table 107. Miracle Medical Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Miracle Medical Needle-free Injection Systems Product
 Table 109. Miracle Medical Recent Developments/Updates
 Table 110. Medical International Technology (MIT) Company Information
 Table 111. Medical International Technology (MIT) Description and Business Overview
 Table 112. Medical International Technology (MIT) Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Medical International Technology (MIT) Needle-free Injection Systems Product
 Table 114. Medical International Technology (MIT) Recent Developments/Updates
 Table 115. Akra Dermojet Company Information
 Table 116. Akra Dermojet Description and Business Overview
 Table 117. Akra Dermojet Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Akra Dermojet Needle-free Injection Systems Product
 Table 119. Akra Dermojet Recent Developments/Updates
 Table 120. PharmaJet Company Information
 Table 121. PharmaJet Description and Business Overview
 Table 122. PharmaJet Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. PharmaJet Needle-free Injection Systems Product
 Table 124. PharmaJet Recent Developments/Updates
 Table 125. Portal Instruments Company Information
 Table 126. Portal Instruments Description and Business Overview
 Table 127. Portal Instruments Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Portal Instruments Needle-free Injection Systems Product
 Table 129. Portal Instruments Recent Developments/Updates
 Table 130. Crossject Medical Technology Company Information
 Table 131. Crossject Medical Technology Description and Business Overview
 Table 132. Crossject Medical Technology Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Crossject Medical Technology Needle-free Injection Systems Product
 Table 134. Crossject Medical Technology Recent Developments/Updates
 Table 135. MIKA MEDICAL Company Information
 Table 136. MIKA MEDICAL Description and Business Overview
 Table 137. MIKA MEDICAL Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. MIKA MEDICAL Needle-free Injection Systems Product
 Table 139. MIKA MEDICAL Recent Developments/Updates
 Table 140. Ferring Pharmaceuticals Company Information
 Table 141. Ferring Pharmaceuticals Description and Business Overview
 Table 142. Ferring Pharmaceuticals Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Ferring Pharmaceuticals Needle-free Injection Systems Product
 Table 144. Ferring Pharmaceuticals Recent Developments/Updates
 Table 145. D'Antonio Consultants International Company Information
 Table 146. D'Antonio Consultants International Description and Business Overview
 Table 147. D'Antonio Consultants International Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. D'Antonio Consultants International Needle-free Injection Systems Product
 Table 149. D'Antonio Consultants International Recent Developments/Updates
 Table 150. Lepu Medical Company Information
 Table 151. Lepu Medical Description and Business Overview
 Table 152. Lepu Medical Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Lepu Medical Needle-free Injection Systems Product
 Table 154. Lepu Medical Recent Developments/Updates
 Table 155. TECHiJET Company Information
 Table 156. TECHiJET Description and Business Overview
 Table 157. TECHiJET Needle-free Injection Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. TECHiJET Needle-free Injection Systems Product
 Table 159. TECHiJET Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Needle-free Injection Systems Distributors List
 Table 163. Needle-free Injection Systems Customers List
 Table 164. Needle-free Injection Systems Market Trends
 Table 165. Needle-free Injection Systems Market Drivers
 Table 166. Needle-free Injection Systems Market Challenges
 Table 167. Needle-free Injection Systems Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Needle-free Injection Systems
 Figure 2. Global Needle-free Injection Systems Market Value by Power (US$ Million), 2021–2032
 Figure 3. Global Needle-free Injection Systems Market Share by Power: 2025 & 2032
 Figure 4. Reusable Injector Product Picture
 Figure 5. Single-use Injector Product Picture
 Figure 6. Global Needle-free Injection Systems Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Needle-free Injection Systems Market Share by Application: 2025 & 2032
 Figure 8. Vaccine Delivery
 Figure 9. Insulin Delivery
 Figure 10. Others
 Figure 11. Global Needle-free Injection Systems Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Needle-free Injection Systems Market Size (US$ Million), 2021–2032
 Figure 13. Global Needle-free Injection Systems Sales (K Units), 2021–2032
 Figure 14. Global Needle-free Injection Systems Average Price (US$/Unit), 2021–2032
 Figure 15. Needle-free Injection Systems Report Years Considered
 Figure 16. Needle-free Injection Systems Sales Share by Manufacturers in 2025
 Figure 17. Global Needle-free Injection Systems Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Needle-free Injection Systems Players: Market Share by Revenue in Needle-free Injection Systems in 2025
 Figure 19. Needle-free Injection Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Needle-free Injection Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Needle-free Injection Systems Sales Market Share by Country (2021–2032)
 Figure 22. North America Needle-free Injection Systems Revenue Market Share by Country (2021–2032)
 Figure 23. United States Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Needle-free Injection Systems Sales Market Share by Country (2021–2032)
 Figure 26. Europe Needle-free Injection Systems Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Needle-free Injection Systems Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Needle-free Injection Systems Revenue Market Share by Region (2021–2032)
 Figure 34. China Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Needle-free Injection Systems Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Needle-free Injection Systems Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Needle-free Injection Systems Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Needle-free Injection Systems Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Needle-free Injection Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Needle-free Injection Systems by Power (2021–2032)
 Figure 54. Global Revenue Market Share of Needle-free Injection Systems by Power (2021–2032)
 Figure 55. Global Needle-free Injection Systems Price (US$/Unit) by Power (2021–2032)
 Figure 56. Global Sales Market Share of Needle-free Injection Systems by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Needle-free Injection Systems by Application (2021–2032)
 Figure 58. Global Needle-free Injection Systems Price (US$/Unit) by Application (2021–2032)
 Figure 59. Needle-free Injection Systems Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc